JPWO2023182332A1 - - Google Patents

Info

Publication number
JPWO2023182332A1
JPWO2023182332A1 JP2024510211A JP2024510211A JPWO2023182332A1 JP WO2023182332 A1 JPWO2023182332 A1 JP WO2023182332A1 JP 2024510211 A JP2024510211 A JP 2024510211A JP 2024510211 A JP2024510211 A JP 2024510211A JP WO2023182332 A1 JPWO2023182332 A1 JP WO2023182332A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024510211A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023182332A1 publication Critical patent/JPWO2023182332A1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
JP2024510211A 2022-03-22 2023-03-22 Pending JPWO2023182332A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022046074 2022-03-22
PCT/JP2023/011140 WO2023182332A1 (ja) 2022-03-22 2023-03-22 口腔内崩壊錠用の添加剤組成物

Publications (1)

Publication Number Publication Date
JPWO2023182332A1 true JPWO2023182332A1 (https=) 2023-09-28

Family

ID=88101076

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024510211A Pending JPWO2023182332A1 (https=) 2022-03-22 2023-03-22

Country Status (3)

Country Link
US (1) US20250195417A1 (https=)
JP (1) JPWO2023182332A1 (https=)
WO (1) WO2023182332A1 (https=)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729926B2 (ja) * 1989-07-25 1995-04-05 大塚製薬株式会社 易吸収性製剤用組成物
JP2009132698A (ja) * 2007-11-06 2009-06-18 Nippon Kayaku Co Ltd 抗アンドロゲン薬の速崩壊性錠剤
TWI441658B (zh) * 2008-03-11 2014-06-21 Takeda Pharmaceutical 口腔崩解固體製劑
JP4257865B1 (ja) * 2008-11-19 2009-04-22 秋山錠剤株式会社 口腔内速崩錠の製造方法
JP6308938B2 (ja) * 2014-12-26 2018-04-11 大原薬品工業株式会社 粒状物を製造する方法
JP6659457B2 (ja) * 2015-05-26 2020-03-04 沢井製薬株式会社 ミグリトール含有口腔内崩壊錠
CA3009152C (en) * 2015-12-25 2023-08-15 Toyama Chemical Co., Ltd. Tablet comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof
US11234962B2 (en) * 2016-12-28 2022-02-01 Fujifilm Toyama Chemical Co., Ltd. Pharmaceutical composition and method of manufacturing the same
JP7370126B2 (ja) * 2018-11-27 2023-10-27 日本化薬株式会社 エルロチニブを有効成分とする医薬錠剤
AU2020282470A1 (en) * 2019-05-31 2022-01-27 Jiangsu Hengrui Medicine Co., Ltd. Solid dispersion and preparation method therefor
UY39094A (es) * 2020-02-27 2021-07-30 Hk Inno N Corp Composición farmacéutica que comprende compuesto derivado de bencimidazol

Also Published As

Publication number Publication date
WO2023182332A1 (ja) 2023-09-28
US20250195417A1 (en) 2025-06-19

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001987A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR102022017795A2 (https=)
BY13165U (https=)
BY13159U (https=)
CN307045569S (https=)
CN307044544S (https=)
BY13170U (https=)
BY13169U (https=)
BY13168U (https=)
CN307045964S (https=)
CN307047651S (https=)
BY13166U (https=)
CN307048089S (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260218